These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5116249)

  • 1. Potential folic acid antagonists. 6. Potential irreversible folate reductase inhibitors derived from 2,4-diamino-5-arylazopyrimidines.
    Chatterjee SS; Moran JF; Triggle DJ; Wayne A
    J Med Chem; 1971 Dec; 14(12):1244-5. PubMed ID: 5116249
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential folic acid antagonists. 5. Synthesis and dihydrofolate reductase inhibitory activities of 2-amino-4,6-substituted-5-arylazopyrimidines.
    Chatterjee SS; Ludwig S; Moran JF; Triggle DJ; Wayne A
    J Med Chem; 1971 Dec; 14(12):1237-8. PubMed ID: 5116245
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential folic acid antagonists. 4. Synthesis and dihydrofolate reductase inhibitory activities of 2,4,6-triamino-5-arylazopyrimidines.
    Chatterjee SS; Garrison DR; Kaprove R; Moran JF; Triggle AM; Triggle DJ; Wayne A
    J Med Chem; 1971 Jun; 14(6):499-501. PubMed ID: 5091964
    [No Abstract]   [Full Text] [Related]  

  • 4. Folate antagonists. 4. Antimalarial and antimetabolite effects of 2,4-diamino-6-((benzyl)amino)pyrido(2,3-d)-pyrimidines.
    Davoll J; Clarke J; Elslager EF
    J Med Chem; 1972 Aug; 15(8):837-9. PubMed ID: 5044297
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential folic acid antagonists. I. The antitumor and folic acid reductase inhibitory properties of 6-substituted 2,4-diamino-5-arylazopyrimidines.
    Hampshire J; Hebborn P; Triggle AM; Triggle DJ; Vickers S
    J Med Chem; 1965 Nov; 8(6):745-9. PubMed ID: 5885064
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential folic acid antagonists. 3. The antitumor and folate reductase inhibitory properties of some irreversibly acting 6-N-substituted 2,4,6-triamino-5-(4-carbethoxyphenylazo)pyrimidines.
    Hampshire J; Hebborn P; Triggle AM; Triggle DJ
    J Med Chem; 1968 May; 11(3):583-8. PubMed ID: 5656500
    [No Abstract]   [Full Text] [Related]  

  • 7. 2,4-Diaminothieno(2,3-d)pyrimidines as antifolates and antimalarials. 1. Synthesis of 2,4-diamino-5,6,7,8-tetrahydrothianaphthena(2,3-d)pyrimidines and related compounds.
    Rosowsky A; Chaykovsky M; Chen KK; Lin M; Modest EJ
    J Med Chem; 1973 Mar; 16(3):185-8. PubMed ID: 4632693
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of some 5-arylazopyrimidines on the growth of Streptococcus faecalis.
    Sen D; Chaudhuri SD
    Indian J Biochem; 1970 Sep; 7(3):187-92. PubMed ID: 4252576
    [No Abstract]   [Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of 2,4-diamino-5-methyl-6-substituted-pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.
    Gangjee A; Lin X; Queener SF
    J Med Chem; 2004 Jul; 47(14):3689-92. PubMed ID: 15214795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential antineoplastics. I. 2-Amino-4,6-dimethyl-5-arylazopyrimidines and 1-thiocarbamoyl-3,5-diphenyl-4-arylazopyrazoles.
    Garg HG; Sharma RA
    J Med Chem; 1969 Nov; 12(6):1122-4. PubMed ID: 5351471
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective Pneumocystis carinii dihydrofolate reductase inhibitors: design, synthesis, and biological evaluation of new 2,4-diamino-5-substituted-furo[2,3-d]pyrimidines.
    Gangjee A; Guo X; Queener SF; Cody V; Galitsky N; Luft JR; Pangborn W
    J Med Chem; 1998 Apr; 41(8):1263-71. PubMed ID: 9548816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible enzyme inhibitors. CXVI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-substituted 2,4-diamino-5-phenylpyrimidines. 3.
    Baker BR; Huang PC; Meyer RB
    J Med Chem; 1968 May; 11(3):475-82. PubMed ID: 5241405
    [No Abstract]   [Full Text] [Related]  

  • 13. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
    Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
    J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible enzyme inhibitors. CXX. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-substituted 2,4-diamino-5-phenylpyrimidines with tissue specificity.
    Baker BR; Huang PC
    J Med Chem; 1968 May; 11(3):495-500. PubMed ID: 5241409
    [No Abstract]   [Full Text] [Related]  

  • 15. 2,4-Diaminothieno(2,3-d)pyrimidines as antifolates and antimalarials. 2. Synthesis of 2,4-diaminopyrido(4',3':4,5)thieno(2,3-d)pyrimidines and 2,4-diamino-8H-thiopyrano(4',3':4,5)thieno(2,3-d)pyrimidines.
    Chaykovsky M; Lin M; Rosowsky A; Modest EJ
    J Med Chem; 1973 Mar; 16(3):188-91. PubMed ID: 4632694
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and antifolate activity of new diaminopyrimidines and diaminopurines in enzymatic and cellular systems.
    Kavai I; Mead LH; Drobniak J; Zakrzewski SF
    J Med Chem; 1975 Mar; 18(3):272-5. PubMed ID: 1169322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines.
    Gangjee A; Adair O; Queener SF
    J Med Chem; 1999 Jul; 42(13):2447-55. PubMed ID: 10395486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,4-diamino-6-substituted-5-(4-carbethoxyphenylazo) pyrimidines as irreversible inhibitors of folic acid reductase.
    Hampshire J; Hebborn P; Triggle AM; Triggle DJ
    J Pharm Sci; 1966 Apr; 55(4):453-4. PubMed ID: 5960304
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of 5-methyl-5-deaza nonclassical antifolates as inhibitors of dihydrofolate reductases and as potential antipneumocystis, antitoxoplasma, and antitumor agents.
    Gangjee A; Shi J; Queener SF; Barrows LR; Kisliuk RL
    J Med Chem; 1993 Oct; 36(22):3437-43. PubMed ID: 8230134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate antagonists. 3. 2,4-Diamino-6-(heterocyclic)quinazolines, a novel class of antimetabolites with potent antimalarial and antibacterial activity.
    Elslager EF; Clarke J; Werbel LM; Worth DF; Davoll J
    J Med Chem; 1972 Aug; 15(8):827-36. PubMed ID: 4625530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.